|
07/03/2018 |
14F7 in chronic B-cell lymphoproliferative syndrome |
CIM |
Registered |
|
30/01/2018 |
Bioequivalence of Trienor |
CIDEM |
Registered |
|
22/12/2017 |
Bioequivalence of Efavirenz |
CIDEM |
Registered |
|
29/11/2017 |
Bioequivalence of Zidovudine |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Sildenafil |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Phenytoin |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Diltiazem retard |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Digoxin |
CIDEM |
Registered |
|
03/11/2017 |
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I |
CIM |
Registered |
|
17/10/2017 |
Bioequivalence of Clopidogrel |
CIDEM |
Registered |
|
16/10/2017 |
Chitosan Unguent in burned patients |
CIDEM |
Registered |
|
13/10/2017 |
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect) |
FINLAY |
Registered outdated |
|
04/10/2017 |
Bioequivalence of diclofenac sodium retard |
CIDEM |
Registered |
|
29/09/2017 |
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
CENSA |
Registered |
|
27/09/2017 |
Bioequivalence of Abacavir |
CIDEM |
Registered |
|
05/09/2017 |
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma |
CIM |
Registered |
|
15/08/2017 |
Bioactive formulation to treat osteoarthritis |
SSA |
Registered |
|
15/08/2017 |
Homeostec for chronic arthritis |
SSA |
Registered |
|
15/08/2017 |
Phenamate in the treatment of prostate cancer |
SSA |
Registered |
|
14/08/2017 |
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III |
BIOCEN |
Registered outdated |
